ARCHIVES

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

This article is from The Cancer Letter archive.

Vol. 21 No. 11 | March 17, 1995

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988